Lilly Buys Rights To Intranasal Diabetes Treatment
October 09, 2015 at 16:16 PM EDT
Eli Lilly & Co. said Friday it bought the rights to a potential treatment for severe hypoglycemia in people with diabetes from Locemia Solutions.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.